Biobase said this week that the Luxembourg Center for Systems Biomedicine will use its Genome Trax software to analyze next-generation sequencing data for use in clinical diagnostics.
Additionally, Biobase said that it will work with LCSB to establish “a hub of expertise” for the application of the company’s products and to provide data analysis, training, and support to researchers in Luxembourg and surrounding countries.
In a statement, Reinhard Schneider, who heads the bioinformatics core facility at LCSB, said that the mutation, regulation, and pharmacogenomics data in Genome Trax are “crucial for the annotation of our clinical data.”
He described LCSB’s collaboration with Biobase “as a strategic partnership to advance the clinical application of NGS technology."
Genome Trax helps users prioritize human genome variants in whole-genome or exome data. The tool maps NGS data to known features such as disease mutations and regulatory sites, allowing users identify novel mutations that could affect the function of candidate disease genes.